Bioengineer

JULY 15, 2021

“We’re excited–with such low doses of radiation, we didn’t expect the response to be so positive,” said lead author Ravi Patel, M.D., In addition to the mouse studies, the physician-scientists worked together with David Vail, D.V.M., This agent was developed by one of the co-authors, Jamey Weichert, Ph.D.,

Medicine 52

Medicine Clinical Trials Clinical Trials Scientist 52

The Pharma Data

DECEMBER 23, 2020

scientists and public health experts, it was announced that there was a growing new strain of the SARS-CoV-2 virus that causes COVID-19. Not all scientists believe it is more contagious, although most are wondering how B.1.1.7 Davidoff Department of Neurological Surgery and of radiology at Einstein. The strain, B.1.1.7

Research 52

Research Protein Gene Vaccination 52

XTalks

SEPTEMBER 14, 2020

It was recently reported that the addition of an adjuvant to their vaccine led to enhanced immune responses that exceeded responses in convalescent serum from symptomatic COVID-19 patients. Novavax has also tested its recombinant SARS-CoV-2 nanoparticle adjuvanted vaccine in a Phase I/II trial.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92